Dr Robert Love, 41, from Miami Beach, Florida , is a researcher and educator who specialises in helping prevent Alzheimer's ...

As The Lantern at Morning Pointe Alzheimer’s Center of Excellence, East Hamilton gets closer to opening, three central ...

Our grey matter has always been a mystery, even to neurologists, but Professor Masud Husain says life-changing advances may ...

Trump's freezing of U.S. foreign aid has stopped work in most military and security assistance programs including in Ukraine ...

Key cells in the brain, neurons, form networks by exchanging signals, enabling the brain to learn and adapt at incredible speed. Researchers have now developed a 3D-printed 'brain-like environment' ...

During the program, attendees will learn how caregiving affects finances and what financial documents caregivers should put in place.

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

AbbVie Inc.'s stock rose 4% early Friday, after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs delivered growth needed to ...

Going out to restaurants, playing bingo, visiting friends, or attending religious services could give you extra years of healthy brain function, according to new research from Rush University Medical ...

European Union regulators will review new information relating to the safety of Eisai Co.’s and Biogen Inc.’s medicine for ...

Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

The European Commission has requested its medicines regulator to consider safety information on Eisai and Biogen's ...